Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mannitol Adjuvant Administration for Delerium Prevention

NCT06759259 is registered in ClinicalTrials.gov with Tomsk National Research Medical Center of the Russian Academy of Sciences as lead sponsor.

NCT NCT06759259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06759259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mannitol Adjuvant Administration for Delerium Prevention
Lead sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Phase
Observational
Overall status
Completed
Start date
December 29, 2024
Completion date
October 1, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium, intensive care unit, randomised controlled trial, myocardial infarction (mi)